221 related articles for article (PubMed ID: 27373636)
1. Design, Synthesis and Biological Evaluation of a Structurally Simplified Syringolin A Analogues.
Chiba T; Kitahata S; Matsuda A; Ichikawa S
Chem Pharm Bull (Tokyo); 2016; 64(7):811-6. PubMed ID: 27373636
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship study of syringolin A as a potential anticancer agent.
Chiba T; Matsuda A; Ichikawa S
Bioorg Med Chem Lett; 2015 Nov; 25(21):4872-4877. PubMed ID: 26231162
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Biological Activity of Isosyringolin A.
Kitahata S; Chiba T; Yoshida T; Ri M; Iida S; Matsuda A; Ichikawa S
Org Lett; 2016 May; 18(9):2312-5. PubMed ID: 27123978
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic simplified tubulysin analogues.
Raghavan B; Balasubramanian R; Steele JC; Sackett DL; Fecik RA
J Med Chem; 2008 Mar; 51(6):1530-3. PubMed ID: 18314944
[TBL] [Abstract][Full Text] [Related]
5. Activity enhancement of the synthetic syrbactin proteasome inhibitor hybrid and biological evaluation in tumor cells.
Archer CR; Groll M; Stein ML; Schellenberg B; Clerc J; Kaiser M; Kondratyuk TP; Pezzuto JM; Dudler R; Bachmann AS
Biochemistry; 2012 Aug; 51(34):6880-8. PubMed ID: 22870914
[TBL] [Abstract][Full Text] [Related]
6. Linear TMC-95-based proteasome inhibitors.
Basse N; Piguel S; Papapostolou D; Ferrier-Berthelot A; Richy N; Pagano M; Sarthou P; Sobczak-Thépot J; Reboud-Ravaux M; Vidal J
J Med Chem; 2007 Jun; 50(12):2842-50. PubMed ID: 17511440
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, conformational analysis, and cytotoxicity of new analogues of the natural cyclodepsipeptide jaspamide.
Terracciano S; Bruno I; Bifulco G; Copper JE; Smith CD; Gomez-Paloma L; Riccio R
J Nat Prod; 2004 Aug; 67(8):1325-31. PubMed ID: 15332850
[TBL] [Abstract][Full Text] [Related]
8. Syringolin B-inspired proteasome inhibitor analogue TIR-203 exhibits enhanced biological activity in multiple myeloma and neuroblastoma.
Opoku-Ansah J; Ibarra-Rivera TR; Pirrung MC; Bachmann AS
Pharm Biol; 2012 Jan; 50(1):25-9. PubMed ID: 22196580
[TBL] [Abstract][Full Text] [Related]
9. Total synthesis of syringolin A and improvement of its biological activity.
Chiba T; Hosono H; Nakagawa K; Asaka M; Takeda H; Matsuda A; Ichikawa S
Angew Chem Int Ed Engl; 2014 May; 53(19):4836-9. PubMed ID: 24668894
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and activity evaluation of the cyclic dipeptides arylidene N-alkoxydiketopiperazines.
Tian X; Feng J; Fan SM; Zhen XL; Han JR; Liu SX
Bioorg Med Chem; 2016 Nov; 24(21):5197-5205. PubMed ID: 27594550
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Ring-Closing Metathesis for the Construction of the Solomonamide Macrocyclic Core: Identification of Bioactive Precursors.
Cheng-Sánchez I; Carrillo P; Sánchez-Ruiz A; Martínez-Poveda B; Quesada AR; Medina MA; López-Romero JM; Sarabia F
J Org Chem; 2018 May; 83(10):5365-5383. PubMed ID: 29676156
[TBL] [Abstract][Full Text] [Related]
12. First generation design, synthesis, and evaluation of azepine-based cryptophycin analogues.
Smith AB; Cho YS; Zawacki LE; Hirschmann R; Pettit GR
Org Lett; 2001 Dec; 3(25):4063-6. PubMed ID: 11735585
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological studies of neopetrosiamides as inhibitors of cancer cell invasion.
Towle KM; Chaytor JL; Liu H; Austin P; Roberge M; Roskelley CD; Vederas JC
Org Biomol Chem; 2013 Mar; 11(9):1476-81. PubMed ID: 23334605
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design of human immuno- and constitutive proteasomes inhibitors.
Richy N; Sarraf D; Maréchal X; Janmamode N; Le Guével R; Genin E; Reboud-Ravaux M; Vidal J
Eur J Med Chem; 2018 Feb; 145():570-587. PubMed ID: 29339252
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives.
Liu Y; Qian K; Wang CY; Chen CH; Yang X; Lee KH
Bioorg Med Chem Lett; 2012 Dec; 22(24):7530-3. PubMed ID: 23122524
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship studies of targeting ligands against breast cancer cells.
Yao N; Xiao W; Meza L; Tseng H; Chuck M; Lam KS
J Med Chem; 2009 Nov; 52(21):6744-51. PubMed ID: 19835381
[TBL] [Abstract][Full Text] [Related]
17. Total synthesis and anti-tubulin activity of epi-c3 analogues of cryptophycin-24.
Buck SB; Huff JK; Himes RH; Georg GI
J Med Chem; 2004 Jul; 47(14):3697-9. PubMed ID: 15214797
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of FAJANU: a de novo C(2) symmetric cyclopeptide family.
Garcia-Martin F; Cruz LJ; Rodriguez-Mias RA; Giralt E; Albericio F
J Med Chem; 2008 Jun; 51(11):3194-202. PubMed ID: 18461923
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of tripeptidyl furylketones as selective inhibitors against the β5 subunit of human 20S proteasome.
Sun Q; Zhou T; Xi D; Li X; Lü Z; Xu F; Wang C; Niu Y; Xu P
Eur J Med Chem; 2020 Apr; 192():112160. PubMed ID: 32146375
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
Hao J; Liu J; Wen X; Sun H
Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
